[Molecular mechanisms of cellular resistance to antifolates].
D000818:Animals; D001682:Biological Availability; D001692:Biological Transport; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D006224:Cricetinae; D003412:Cricetulus; D004351:Drug Resistance; D004789:Enzyme Activation / Q000187:drug effects; D004790:Enzyme Induction / Q000187:drug effects; D006801:Humans; D007939:Leukemia L1210 / Q000188:drug therapy; D008727:Methotrexate / Q000378:metabolism / Q000627:therapeutic use*; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology; D012333:RNA, Messenger / Q000235:genetics; D012334:RNA, Neoplasm / Q000235:genetics; D013762:Tetrahydrofolate Dehydrogenase / Q000096:biosynthesis
D012333:RNA, Messenger; D012334:RNA, Neoplasm; D013762:Tetrahydrofolate Dehydrogenase; D008727:Methotrexate
Molekularne mechanizmy oporności komórek na antyfoliany.